Momenta, BioFactura in Drug Engineering Pact
By

By
Momenta Pharmaceuticals, a biotechnology company based in Cambridge, Massachusetts, has entered into a non-exclusive license agreement with BioFactura, a Frederick, Maryland-based biopharmaceutical research and manufacturing company, relating to one of the…

Genentech, BioNTech Partner on mRNA Cancer Vaccines
By

By
Genentech, part of Roche, has formed a worldwide strategic collaboration with BioNTech AG, a Mainz, Germany-based biotechnology company developing personalized cancer immunotherapies, to develop, manufacture, and commercialize messenger RNA (mRNA)-based,…

AbbVie, BioArctic in Pact for Parkinson’s Disease
By

By
AbbVie has formed a collaboration with BioArctic, a Stockholm, Sweden-based biopharmaceutical company, to develop and commercialize BioArctic’s portfolio of antibodies directed against alpha-synuclein for treating Parkinson’s disease and other potential…

Takeda, Affilogic Partner in CNS Therapies
By

By
Takeda Pharmaceutical has formed a research collaboration with Affilogic, a Nantes, France-based biotechnology company, to explore using Nanofitins, Affilogic’s proprietary antibody-mimetics platform, in therapies targeting the central nervous system. Specifically, Affilogic and…

Takeda, Zydus Cadila Partner to Tackle Infectious Disease
By

By
Takeda Pharmaceutical and Zydus Cadila, an Ahmedabad, India-based pharmaceutical company, have formed a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia, and the Indian subcontinent. Terms have…

UCB Opens Innovation Center
By

By
UCB, a biopharmaceuticals company, has opened its UCB Solution Accelerator, an environment designed to drive collaboration between UCB and the Georgia Institute of Technology (Georgia Tech) community. The 2,500-square-foot innovation…

Sanofi Pasteur Gets US Gov’t Funding for Manufacturing Zika Vaccine
By

By
Sanofi and its vaccines global business unit, Sanofi Pasteur, have received a $43.2 million grant from the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant…

Pharma Companies Sign Plan to Combat Antimicrobial Resistance
By

By
Thirteen leading companies have presented a new roadmap for four key commitments that they will deliver by 2020 to reduce antimicrobial resistance (AMR). The commitments follow the principles identified and…

FDA Approves Amgen’s Amjevita, a Humira Biosimilar
By

By
Amgen has received approval from the US Food and Drug Administration (FDA) for Amjevita (adalimumab-atto) across all eligible indications of the reference product, Humira (adalimumab), AbbVie’s anti tumor necrosis factor…

Endo Names New CEO and President
By

By
Endo International’s board of directors has named Paul V. Campanelli president and chief executive officer (CEO), effective immediately. Mr. Campanelli currently serves as president of Endo’s generic and over-the-counter drug…